EUVIMEDScopri EUVIMED
Leserbrief

Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure

Yakup Demir iD

Alimentary Pharmacology & Therapeutics · 2026-10-16

DOI: 10.1111/apt.71059 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-10-16. Written by Yakup Demir. Institution: Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye. Cited 1 times so far (Crossref); 6 references.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Authors and institutions

  • Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye.

ORCID profiles: Yakup Demir

Cite

APA

Demir, Y. (2026). Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71059

Vancouver

Demir Y. Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71059

BibTeX
@article{Demir2026,
  author = {Demir, Yakup},
  title = {Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71059}
}
Start for free →